These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 36548725

  • 1. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins.
    Guerre P, Gilleron C, Matard-Mann M, Nyvall Collén P.
    Toxins (Basel); 2022 Nov 24; 14(12):. PubMed ID: 36548725
    [Abstract] [Full Text] [Related]

  • 2. Targeted sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain.
    Guerre P, Matard-Mann M, Nyvall Collén P.
    Food Chem Toxicol; 2022 Dec 24; 170():113467. PubMed ID: 36241089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens.
    Lassallette E, Collén PN, Guerre P.
    Ecotoxicol Environ Saf; 2023 Dec 24; 268():115697. PubMed ID: 37979349
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fumonisins alone or mixed with other fusariotoxins increase the C22-24:C16 sphingolipid ratios in chicken livers, while deoxynivalenol and zearalenone have no effect.
    Guerre P, Lassallette E, Beaujardin-Daurian U, Travel A.
    Chem Biol Interact; 2024 May 25; 395():111005. PubMed ID: 38615975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
    Soriano JM, González L, Catalá AI.
    Prog Lipid Res; 2005 Nov 25; 44(6):345-56. PubMed ID: 16266752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
    Schroeder JJ, Crane HM, Xia J, Liotta DC, Merrill AH.
    J Biol Chem; 1994 Feb 04; 269(5):3475-81. PubMed ID: 8106389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
    Wakita H, Nishimura K, Tokura Y, Furukawa F, Takigawa M.
    J Invest Dermatol; 1996 Sep 04; 107(3):336-42. PubMed ID: 8751967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.